Min Sun

Title: Innovator Spotlight: Min Sun's Contributions to Pharmaceutical Advancements

Introduction: Min Sun, a prominent inventor based in Kunming, China, has made significant strides in the field of pharmaceuticals. With one patented invention to his name, Sun is a key figure at the Yunnan Institute of Materia Medica, where his research and innovation have the potential to impact mood disorder treatments.

Latest Patents: Min Sun's noteworthy patent is titled "Polymorph of triaryldimethylpiperazine dihydrochloride and preparation method and application thereof." This patent outlines five polymorph forms (B, P, F, J, O) of a specific compound designed to address mood disorders or diseases associated with the δ-opioid receptor. The patented preparation methods and applications demonstrate the potential for this compound in the development of medicaments aimed at improving mental health.

Career Highlights: As an inventor affiliated with the Yunnan Institute of Materia Medica, Min Sun has dedicated his career to exploring innovative solutions within the pharmaceutical sector. His work emphasizes a commitment to advancing medicinal chemistry and offering new avenues for treatment in mental health.

Collaborations: Min Sun collaborates with esteemed colleagues, including Jingkun Wang and Zhaoyun Zhu. Together, they contribute to a productive research environment that fosters innovation and addresses critical health issues.

Conclusion: Min Sun's inventive contributions exemplify the vital role that dedicated researchers play in the advancement of medical science. With his focus on the development of effective medications for mood disorders, Sun's innovations are poised to make a lasting impact on patient care and treatment methodologies.